Accelerating Discovery and Development: Reducing Risk with High Performance Transfection of the Right Cell for the Right Application

2021-10-11T19:02:54+00:00May 16th, 2020|Comments Off on Accelerating Discovery and Development: Reducing Risk with High Performance Transfection of the Right Cell for the Right Application

Development of anti-human mesothelin-targeted chimeric antigen receptor (CAR) messenger RNA (mRNA)-transfected peripheral blood lymphocytes (CARMA-hMeso) for ovarian cancer therapy

2021-10-12T20:58:17+00:00May 18th, 2018|Comments Off on Development of anti-human mesothelin-targeted chimeric antigen receptor (CAR) messenger RNA (mRNA)-transfected peripheral blood lymphocytes (CARMA-hMeso) for ovarian cancer therapy

CRISPR-Cas9 Gene Repair of Hematopoietic Stem Cells From Patients With X-linked Chronic Granulomatous Disease

2021-10-04T16:29:50+00:00June 1st, 2017|Comments Off on CRISPR-Cas9 Gene Repair of Hematopoietic Stem Cells From Patients With X-linked Chronic Granulomatous Disease
Go to Top